ALPINE IMMUNE SCIENCES, INC.

SEATTLE, WA · Biotech · Acquired

Therapeutic antibodies and immunomodulatory proteins for immune-mediated diseases

Claim this profile

Follows are private to you and power your alerts

Updated · alpine.ai

Sector
Biotech
Headquarters
SEATTLE, WA
Latest Form D
$91M, Sep 2021
Total capital
$206M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$206M
4 Form D · last Sep 2021
61 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
24
16 pending · first 2022
Rank in peer group#58 of 1449

Capital timeline

20142015201620172018201920202021FEDERAL ↑EQUITY ↓Cumulative $206M1st Form D$30M2nd Form D$25.3M3rd Form D$60M
2014201620182020FEDERAL ↑EQUITY ↓Cumulative $206M1st Form D$30M

Latest events

  • Private capital raisedForm D · SEC · 4th filing$91M
  • Private capital raisedForm D · SEC · 3rd filing$60M
  • Private capital raisedForm D · SEC · 2nd filing$25.3M
  • Private capital raisedForm D · SEC · 1st filing$30M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1449 peers

Line = median

Biotech · Molecule

  • Granted patents#58 · top 4%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Christopher James PeetzDirectorNamed in SEC Form D filings
  • Cui Paul XiangminDirectorNamed in SEC Form D filings
  • David H. MillerExecutive OfficerNamed in SEC Form D filings
  • Dr. Mitchell H GoldExecutive Officer, DirectorNamed in SEC Form D filings
  • James Paul RickeyExecutive OfficerNamed in SEC Form D filings
  • James Paul TopperDirectorNamed in SEC Form D filings
Show all 19 people
  • Jay Paul VenkatesanDirectorNamed in SEC Form D filings
  • J. Paul H. RickeyExecutive OfficerNamed in SEC Form D filings
  • Mark James LittonExecutive OfficerNamed in SEC Form D filings
  • Michael H KornackerExecutive Officer, DirectorNamed in SEC Form D filings
  • Mitchell Paul GoldExecutive Officer, DirectorNamed in SEC Form D filings
  • Natasha Paul HerndayDirectorNamed in SEC Form D filings
  • Paul James SekhriDirectorNamed in SEC Form D filings
  • Peter James ThompsonDirectorNamed in SEC Form D filings
  • Robert James ConwayDirectorNamed in SEC Form D filings
  • Ryan H SwansonExecutive Officer, DirectorNamed in SEC Form D filings
  • Stanford H. PangExecutive OfficerNamed in SEC Form D filings
  • Stanford James PengExecutive OfficerNamed in SEC Form D filings
  • Zelanna Paul GoldbergExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 24 granted of 40
Show all 40 patent records
  • New Frontier Bio, Inc.Similar federal contract value in Biotech · null in contracts
  • Lattice Biologics Ltd.Similar federal contract value in Biotech · null in contracts
  • EnGeneIC LtdSimilar federal contract value in Biotech · null in contracts
  • Okogen, Inc.Similar federal contract value in Biotech · null in contracts
  • Protagenic Therapeutics, Inc.\newSimilar federal contract value in Biotech · null in contracts
  • GREENLAB, INC.Similar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .